Jacques Galipeau is a Professor at Emory University, Director of Emory Personalized Immunotherapy Center. Readers of this blog may remember Jacques Galipeau as the author of the first-of-its-kind analysis “why mesenchymal stromal cells did not work in industry trials“. He is prominent translational MSC researcher and an investigator in clinical trials. His talks and published studies are always capture a lot of attention and facilitate productive discussions in the field.
This talk was recorded during annual World Stem Cell Summit in December of 2015. I’d highly recommend you to watch whole talk!